跳至主要内容
临床试验/ITMCTR2000003502
ITMCTR2000003502尚未招募4 期

Traditional Chinese medicine syndrome characteristics of chronic hepatitis B patients with renal function damage and bone mineral density reduction after antiviral treatment and improvement of bone mineral density in chronic hepatitis B patients treated with tenofovir alafenamide fumarate

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) having a history of chronic hepatitis B.
  • (2) Nucleoside (acid) antiviral treatment >= 24 weeks.
  • (3) willing to cooperate with the study and sign the informed consent.
  • (1) having a history of chronic hepatitis B.
  • (2) Age: 18-65 years old.
  • (3) Nucleoside (acid) antiviral treatment >= 24 weeks.
  • (4) combined with bone mineral density decreased.
  • (5) willing to cooperate with the research and sign the informed consent.

排除标准

  • (1) With a definite history of chronic kidney disease or osteoporosis before antiviral therapy.
  • (2) In addition to antiviral drugs, receiving kidney damage drugs or glucocorticoids that can lead to osteoporosis.
  • (3) Pregnant or lactating women.
  • (1) With a definite history of chronic kidney disease or osteoporosis before antiviral therapy.
  • (2) In addition to antiviral drugs, receiving kidney damage drugs or glucocorticoids that can lead to osteoporosis.
  • (3) Co-infection with HAV, HCV, HDV, HEV or HIV.
  • (4) Combined with pituitary, parathyroid and other diseases that affect calcium and phosphorus metabolism,or receiving drugs affecting calcium and phosphorus metabolism.
  • (5) Combined with secondary liver disease caused by severe malnutrition, total parenteral nutrition, weight loss after bariatric surgery, drug, environmental or industrial toxicosis.
  • (6) Combined with cardiovascular, brain, kidney and other serious organic diseases and severe primary diseases of hematopoietic system.
  • (7) Patients with poor compliance and unable to adhere to treatment.
  • (8) combined with liver cancer or cancers of other organs.
  • (9) Pregnant or lactating women.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验

Traditional Chinese medicine syndrome... | 临床试验